Asia SPAC Pioneer
Selected Case Study
DT Asia Investments Limited
DT Asia Investments Limited (NASDAQ: CADT) went public in the U.S. as a SPAC and was awarded the Best IPO of 2014 by Acquisition International.
DT Asia Investments Limited was one of the few U.S. SPACs targeting the Asian market after the 2008 financial crisis.
Following the business combination, the newly-formed entity now operates under the name Lending Group (later renamed Roan Holdings Group Co., Ltd., NASDAQ: RAHGF), a direct lending company based in the Xinjiang Uyghur Autonomous Region of China.
July 6, 2016
Tottenham Acquisition I Limited
Tottenham Acquisition I Limited (TOTA) went public on the U.S. Nasdaq, marking itself as the pioneer among Asia-backed SPACs to complete a merger with a U.S.-based biopharmaceutical company.
Following the business combination, the newly-formed entity now operates under the name Clene Inc. (NASDAQ: CLNN), with a primary focus on developing innovative therapeutic candidates for neurodegenerative diseases.
Clene has an exceptional management team, robust shareholder and advisory backgrounds, extensive professional expertise in biotechnology, and substantial intellectual property, creating significant entry barriers.
December 30, 2020
Keen Vision Acquisition Corporation
Keen Vision Acquisition Corporation (NASDAQ: KVAC) made its debut on NASDAQ on July 24, 2023, with nearly four times oversubscription. In March 2024, KVAC signed a letter of intent for business combination with a Boston-based biopharmaceutical firm.
The company specializes in developing cutting-edge human stem cell technology and next-gen cell/gene therapies for challenging diseases. Its pipeline, FDA-approved, is undergoing clinical trials at leading US hospitals.